Skip to main content
Menu closed
  • House Patients and Caregivers Home
    • Is BAQSIMI for me?
    • What is BAQSIMI?
    • When to use BAQSIMI?
      • About low blood sugar emergencies
      • Possible signs of low blood sugar
    • How to use BAQSIMI?
    • BAQSIMI basics
  • For Healthcare Providers
    • Pediatric Patients Home
      • Efficacy
      • Safety
      • Administration/Usage
      • MOA
    • Adult Patients Home
      • Efficacy
      • Safety
      • Administration/Usage
      • MOA
    • BAQSIMI Product Monograph
    • Severe Hypoglycemia Information
  • Got Your BAQ™ Resources
Globe Loading... Reveal available languages

When to use BAQSIMI?

  • BAQSIMI is used when you are having a low blood sugar emergency and are unable to eat or drink, requiring help from someone else to recover.
  • It’s important that people around you recognize the possible signs of a low blood sugar, so they can be prepared to help.
  • Show your family, friends, or coworkers where you keep BAQSIMI and explain how to use it by sharing these instructions. They need to know how to use BAQSIMI before you need it.
  • Tell your doctor each time you use BAQSIMI. Your doctor may need to adjust your dose of drugs for diabetes.

A low blood sugar emergency can happen anytime, anywhere

For example, these episodes can happen when you miss a meal, exercise too much, do not eat enough food for the amount of insulin taken, or even at night while you sleep.

BAQSIMI is a dry nasal powder that can be given by those around you during a low blood sugar emergency.

Possible signs of low blood sugar include:

ICON Moody Faces

Mood swings

ICON Dizzy Figure

Dizziness

ICON Slipping Figure

Lack of coordination

ICON Head with question mark

Difficulty thinking and speaking

ICON head with sweat droplets

Shaking or sweating

ICON unconscious figure

Seizure or loss of consciousness

« What is BAQSIMI?
How to use BAQSIMI? »

Clinical use:
BAQSIMI has not been studied in pediatric patients less than 4 years old.

Limited clinical trial experience has not identified difference in responses between elderly (≥65 years of age) and younger patients.



Contraindications:

  • Hypersensitivity to glucagon or to any ingredient in the formulation or container
  • Pheochromocytoma
  • Insulinoma



Most serious warnings and precautions:
Lack of response: BAQSIMI should be given only in patients where impaired consciousness precludes oral carbohydrates. After intranasal administration of BAQSIMI, the patient will normally respond within 15 minutes. If the patient does not respond within 15 minutes, intravenous glucose must be administered as soon as IV access can be established.

States of starvation, adrenal insufficiency or chronic hypoglycemia: Because glucagon is of little or no help in these cases, intravenous glucose should be used for the treatment of hypoglycemia in these conditions.



Other relevant warnings and precautions:

  • Cardiovascular effects
  • Driving and operating machinery
  • Pheochromocytoma
  • Insulinoma
  • Sensitivity and resistance to glucagon
  • Pregnant women
  • Breast-feeding
  • Pediatrics (<4 years of age)
  • Geriatrics (≥65 years of age)
  • Use in patients with Type 2 diabetes taking sulfonylureas
  • Use with alcohol
  • Monitoring and laboratory tests



For more information:
Consult the Product Monograph at http://pi.lilly.com/ca/baqsimi-ca-pm.pdf for additional important information relating to warnings and precautions, adverse reactions, drug interactions and dosing information which have not been discussed in this piece. The Product Monograph is also available by calling 1-888-545-5972.

  • Privacy
  • Terms of Use
  • Disclaimer
  • Accessibility
  • Site map
 

BAQSIMI™ is a trademark owned by or licensed to Eli Lilly and Company, its subsidiaries or affiliates.



PP-GN-CA-0018 © Eli Lilly Canada Inc. 2021

Privacy Terms of Use Disclaimer Accessibility Site map
Lilly